Accuracy of Dynamic Navigation System on Zygomatic Implant Placement
Launched by UNIVERSITY OF BARCELONA · Dec 2, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method for placing zygomatic implants, which are special dental implants used for patients who have lost teeth in the upper jaw and may not have enough bone for traditional implants. The trial compares the accuracy of using a dynamic navigation system—like a GPS for surgery—versus the standard freehand technique. The goal is to see if the new system can help place these implants more precisely.
To join the study, participants must be adults over 18 years old who have partial or total tooth loss in the upper jaw and significant bone loss that makes regular implant placement difficult. Unfortunately, people with certain facial bone diseases or health conditions that could complicate surgery cannot participate. Those who take part in the trial will help researchers learn more about this innovative approach, and they can expect to receive careful monitoring and support throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Partial or total edentulous maxilla
- • Large bone atrophy that avoids possible conventional implant placement
- • Over 18 years old patients
- Exclusion Criteria:
- • Patients with facial bone disease that contraindicates conventional or zygomatic implants placement.
- • Systemic or local conditions that contraindicates oral surgery.
About University Of Barcelona
The University of Barcelona, a prestigious institution renowned for its commitment to research and academic excellence, serves as a leading sponsor for clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a rich history of innovation and collaboration, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research across various fields, including medicine, pharmacology, and public health. Through its robust network of partnerships with healthcare providers and research organizations, the University of Barcelona is dedicated to fostering advancements in clinical practice and contributing to the development of effective therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
L'hospitalet De Llobregat, Barcelona, Spain
Patients applied
AG
AS
NB
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported